Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Glycine, mixt. with 3,9-dihydro-1,3-dimethyl-1H-purine-2,6-dione sodium salt (1:1)

Glycine, mixt. with 3,9-dihydro-1,3-dimethyl-1H-purine-2,6-dione sodium salt (1:1)

Glycine, mixt. with 3,9-dihydro-1,3-dimethyl-1H-purine-2,6-dione sodium salt (1:1) structure

Glycine, mixt. with 3,9-dihydro-1,3-dimethyl-1H-purine-2,6-dione sodium salt (1:1) 

structure
  • CAS No:

    8000-10-0

  • Formula:

    C7H8N4O2.C2H5NO2.Na

  • Chemical Name:

    Glycine, mixt. with 3,9-dihydro-1,3-dimethyl-1H-purine-2,6-dione sodium salt (1:1)

  • Synonyms:

    Glycine,mixt. with 3,9-dihydro-1,3-dimethyl-1H-purine-2,6-dione sodium salt (1:1);Glycine,mixt. with 3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione sodium salt;1H-Purine-2,6-dione,3,7-dihydro-1,3-dimethyl-,sodium salt,mixt. contg.;Englate;Theophylline sodium glycinate;Glycin theophyllinate;Bronchoparat;Panophylline;Pemophyllin;Glytheonate

  • Categories:

    Biochemical Engineering  >  Amino Acids and Proteins

Description

A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLYL CYCLASES and cyclic AMP.

Glycine, mixt. with 3,9-dihydro-1,3-dimethyl-1H-purine-2,6-dione sodium salt (1:1) Basic Attributes

277.21

277.07900

616-765-4

2S36N8T753

Characteristics

138.83000

1.05 g/cm3 @ Temp: 20 °C

272 - 274ºC

454.1ºC at 760 mmHg

228.4ºC

Drug Information

Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)|Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)|Compounds that bind to and block the stimulation of PURINERGIC P1 RECEPTORS. (See all compounds classified as Purinergic P1 Receptor Antagonists.)|Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)

1,3 Dimethylxanthine

Glycine, mixt. with 3,9-dihydro-1,3-dimethyl-1H-purine-2,6-dione sodium salt (1:1) Use and Manufacturing

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:277.21
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:1
Exact Mass:277.07869816
Monoisotopic Mass:277.07869816
Topological Polar Surface Area:135
Heavy Atom Count:19
Complexity:314
Covalently-Bonded Unit Count:3
Compound Is Canonicalized:Yes

Recommended Suppliers of Glycine, mixt. with 3,9-dihydro-1,3-dimethyl-1H-purine-2,6-dione sodium salt (1:1)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.